Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 PatientsPiotr K. Krajewski, Jacek C. Szepietowski, Łukasz Matusiak et al.|Life|2021Cited by 69
Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 PatientsPiotr K. Krajewski, Jacek C. Szepietowski, Łukasz Matusiak et al.|Acta Dermato Venereologica|2020Cited by 37
LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled TrialMichael Schultheis, Jacek C. Szepietowski, Petra Staubach et al.|Dermatology|2021Cited by 29
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg StudyHenner Stege, Carmen Loquai, Alexander Kreuter et al.|Cancers|2021Cited by 23
LAight® Therapy Is an Effective Treatment Option to Maintain Long-Term Remission of Hurley I and II Hidradenitis Suppurativa: Results from Period B of RELIEVE, a Multicenter Randomized, Controlled TrialMichael Schultheis, Georgios Nikolakis, Petra Staubach et al.|Dermatology|2022Cited by 11